Envista
DEXIS™ announces a new advancement in implant dentistry workflows with the DEXIS digital ecosystem: an interconnected, AI-powered platform for digital implants - combining cutting-edge CBCT, intraoral scanning, diagnostics, and treatment planning. The ecosystem is designed to empower clinicians to manage each step of an implant case, from diagnosis to delivery, with one integrated tool set.
QUAKERTOWN, PA / ACCESSWIRE / February 12, 2024 / For over 70 years, DEXIS has been committed to providing clinicians with smart tools to accurately diagnose patients, create treatment plans, and achieve desired outcomes. The DEXIS digital ecosystem is no exception and continues to uphold that same tradition of excellence. With this prosthetic-driven implant system, you'll gain access to an open imaging platform, complete with diagnostics and treatment planning software, driven by Assisted Intelligence and tailored specifically for implant workflows.
Recognizing the daily challenges of managing data, processes and expectations, the DEXIS digital ecosystem takes pride in its simplicity. This user-friendly platform allows clinicians to efficiently organize, analyze and plan cases while seamlessly collaborating with team members and partners.
"I can complete each step of a clinical case from within one software - educating the patient, making a diagnosis, creating a treatment plan and gaining acceptance," said Dr. Katya Archambault, Oral and Maxillofacial Radiologist in La Jolla, California. "My staff loves it because they don't have to pull up tons of different programs. It's all just very clear, clean and on the same page."
In late 2023, DEXIS launched the ORTHOPANTOMOGRAPH™ OP 3D™ LX, an advanced cone beam computed tomography technology that enhances 3D diagnostic capabilities with flexible FOV options and short scan times, boosting diagnostic confidence and supporting an evolving practice.
"At DEXIS, our product development team worked with over 200 dentists and their teams to put the customer at the center of our solutions," said Brian Gooch, Global Product Management and Marketing Vice President at DEXIS. "With implant workflows, the DEXIS solution promotes diagnostic confidence and delivers productivity to the office. We are always in motion, driven by a profound commitment to innovate and improve our solutions for clinics striving for a more efficient way of working."
After launching the OP 3D LX, DEXIS announced the release of an upgraded version of its intraoral scanning software - IS ScanFlow. Through guided workflows and the use of AI-powered tools, users can confidently navigate complex scanning situations and consistently acquire accurate data. A good example of this is the new full arch workflow, which assists users in obtaining scan data for full-mouth rehabilitations, providing step-by-step guidance throughout the process.
"We've used the new full arch workflow," said Dr. Robert Pauley, practice owner in Union City, Georgia. "It's very easy to take the common scan with the provisional in place, remove and scan the provisional and then obtain a final scan of the soft tissue with scanbodies."
DEXIS has also brought advancements to the core platform of its digital ecosystem, DTX Studio™ Clinic - an AI-driven diagnostic and treatment planning software. DTX Studio Clinic seamlessly integrates with the DEXIS intraoral scanning solution, serving as the central hub for clinicians to manage all patient data and files. With a clear and reliable source of information for each case, DTX Studio Clinic effortlessly assists with every step of the process, from dental imaging and diagnostics to treatment planning, manufacturing, and follow-up.
With an array of AI-driven tools to enhance the implant process, DTX Studio Clinic prioritizes high productivity and effective communication. Assisted Intelligence streamlines your diagnostics by preparing CBCT images, automatically annotating features like tooth positions and panoramic curves, and tracing the mandibular nerve canal - saving you time and effort. Additionally, the automated merging of CBCT and optical scans creates a realistic 3D digital rendering of a patient's dentition for accurate treatment planning.
Clinicians have the freedom to customize their workflow, while ensuring that patients, labs, and staff have the visibility they need for a seamless experience. This is accomplished through a variety of tools and features, including:
- AI-assisted case setup for chairside diagnostics and treatment planning
- Dynamic view of images, findings and treatment plans all on one screen
- Automatic merging of CBCT and intraoral scans
- AI-powered powered tooth number recognition
- AI-powered automated tooth setup
- AI-powered focus area identification
- Assisted mandibular nerve canal tracing
- Assisted airway identification
- Easy partner access to all digital files
- Cross-practice access to all information from any computer
- Virtual implant library
- Surgical guide creation to 3D print in-house or for outsourcing
- Dynamic surgery with X-Guide
The DEXIS digital ecosystem empowers clinicians to manage their entire implant process with one, integrated toolset, while preserving complete flexibility to adapt their workflows based on the individual needs of each case. With this uniquely connected platform, clinicians now have the freedom to personalize their workflows and the standardization to scale them.
Explore the DEXIS digital ecosystem here.
About DEXIS
DEXIS has been a global leading brand in digital radiography for 70+ years. Today, DEXIS has brought together the most trusted brands in 3D imaging, intraoral scanning solutions, and diagnostic software to provide you with a complete digital diagnostic solution under a brand name. Our innovative award-winning technology enhances the way you diagnose, accelerates your workflow, and delivers simpler treatment paths with better patient outcomes. For more information, please visit https://www.dexis.com.
Contact Information
Hayley Reed
Regional Marketing Director, DEXIS IOS
hayley.reed@envistaco.com
(714) 628-8533
SOURCE: DEXIS
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
eComplete Partners with Sourceful to build AI-Native Creative Operations Across Portfolio18.11.2025 15:00:00 CET | Press release
MANCHESTER, UK / ACCESS Newswire / November 18, 2025 / eComplete, the private equity firm behind Current Body's £300 million London Stock Exchange listing, has announced a strategic partnership with Sourceful, the Manchester-based technology company whose Riverflow 1 model ranks as the world's leading AI image editing model. The partnership brings Sourceful's AI-native creative platform to eComplete's portfolio of direct-to-consumer brands, enabling them to generate brand-accurate, production-ready creative assets at scale across e-commerce, social, marketplace and retail. This makes eComplete the first major private equity investor to adopt AI-native creative infrastructure as a core operational advantage. Why this matters Every consumer brand today faces the same constraint: producing thousands of creative assets, product images, ads, videos, packaging, that feel authentically on-brand across every channel and market. This challenge has intensified dramatically over the past three ye
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom